Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib and acalabrutinib treated patients

Autor: Black, Gage S., Huang, Xiaomeng, Qiao, Yi, Tarapcsak, Szabolcs, Rogers, Kerry A., Misra, Shrilekha, Byrd, John C., Marth, Gabor T., Stephens, Deborah M., Woyach, Jennifer A.
Zdroj: Blood; 20240101, Issue: Preprints
Databáze: Supplemental Index